Blue Trust’s Turn Therapeutics TTRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.1K Hold
1,122
– – ﹤0.01% 1573
2026
Q2
$8.19K Hold
1,122
– – ﹤0.01% 1913
2026
Q1
$3.59K Hold
1,122
– – ﹤0.01% 2048
2025
Q4
$4.42K Buy
+1,122
New +$4.68K ﹤0.01% 2015

Other funds holding TTRX

Blue Trust's TTRX Position: Q3 2026 in Review

Blue Trust held its Turn Therapeutics (TTRX) position steady in Q3 2026 at 1,122 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

Blue Trust first reported a position in TTRX in Q4 2025 and has held it in 4 quarters since. 36 funds tracked by Wall St. Rank hold TTRX as of Q3 2026.

  • Blue Trust held 1,122 shares of Turn Therapeutics worth $16.1K as of Q3 2026.
  • Blue Trust left its Turn Therapeutics share count unchanged in Q3 2026.
  • Turn Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1573 holding.
  • Blue Trust first reported a position in Turn Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • 36 funds tracked by Wall St. Rank held Turn Therapeutics as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.